Research News and Research

RSS

Men with long-term HIV infections at higher risk of developing plaque in their coronary arteries

Men with long-term HIV infections are at higher risk than uninfected men of developing plaque in their coronary arteries, regardless of their other risk factors for coronary artery disease, according to results of a study led by Johns Hopkins researchers. A report on the research appears in the April 1 issue of Annals of Internal Medicine.

1 Apr 2014

Health care spending growth hits decade high

In other news, health care stocks have emerged as robust gainers in a resilient U.S. stock market.

1 Apr 2014

Sleep fragmentation, poor sleep quality associated with decline in executive function

A new study of older men found a link between poor sleep quality and the development of cognitive decline over three to four years.

1 Apr 2014

Extreme summer heat in Montreal may have effect on early-term deliveries

When temperatures reach 32-C or higher over a period of four to seven days, the risk of early-term delivery is 27% higher than on typical summer days, according to a study led by Nathalie Auger of the University of Montreal's Department of Social and Preventive Medicine. The study involved data from 300,000 births that took place in Montreal between 1981 to 2010 with summer temperatures recorded by Environment Canada during this period. Auger is also affiliated with the university's CHUM Superhospital Research Centre.

1 Apr 2014

Retinoic acid helps turn pre-cancer cells back to normal healthy breast cells

A derivative of vitamin A, known as retinoic acid, found abundantly in sweet potato and carrots, helps turn pre-cancer cells back to normal healthy breast cells, according to research published this month in the International Journal of Oncology. The research could help explain why some clinical studies have been unable to see a benefit of vitamin A on cancer: the vitamin doesn't appear to change the course of full-blown cancer, only pre-cancerous cells, and only works at a very narrow dose.

31 Mar 2014

Cognitive deficits in bipolar patients ‘not homogenous’

Patients with bipolar disorder can be separated into three groups based on their cognitive performance, a study suggests.

31 Mar 2014

Americans' experience with health law depends on where they live

Some states that embraced the law, like Oregon, have had difficulty enrolling residents because of glitch-ridden online marketplaces, while others like New Hampshire have seen unexpectedly strong enrollments despite prevailing critical views.

31 Mar 2014

Artists benefit from health law, but rural residents may pay more

Self-employed Americans such as artists stand to gain under the health law, but rural residents may pay more for coverage because of the higher costs of delivering care in a sparsely populated area and the disproportionate number of older people. Other media outlets offer advice for consumers trying to make sense of the law.

31 Mar 2014

Cellulose nanofiber paper filter removes virus particles with high efficiency

Researchers at the Division of Nanotechnology and Functional Materials, Uppsala University have developed a paper filter, which can remove virus particles with the efficiency matching that of the best industrial virus filters. The paper filter consists of 100 percent high purity cellulose nanofibers, directly derived from nature.

31 Mar 2014

CytRx’s aldoxorubicin receives European orphan medicinal product designation for treatment of advanced soft tissue sarcomas

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that aldoxorubicin has received orphan medicinal product designation from the European Commission for the treatment of advanced soft tissue sarcomas. The designation is to encourage the development of drugs which may provide significant benefit to patients suffering from rare diseases.

31 Mar 2014

Bariatric surgery patients report better quality of life

A study by Cleveland Clinic researchers shows bariatric surgery is a highly effective and durable treatment for type 2 diabetes in obese patients, enabling nearly all surgical patients to be free of insulin and many to be free of all diabetic medications three years after surgery.

31 Mar 2014

Concert Pharmaceuticals announces 2013 year-end results; posts record revenue of $25.4M

Concert Pharmaceuticals, Inc. today reported financial results for the year ended December 31, 2013 and provided an update on corporate activities.

31 Mar 2014

New study shows anti-anxiety drugs and sleeping pills associated with increased risk of death

Anti-anxiety drugs and sleeping pills have been linked to an increased risk of death, according to new research from the University of Warwick.

31 Mar 2014

ICON agrees to acquire Aptiv Solutions for $143.5 million

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has agreed, subject to certain closing conditions, to acquire Aptiv Solutions for a cash consideration of $143.5 million. Aptiv Solutions is owned by The Halifax Group, SV Life Sciences, Comvest Partners and Management.

31 Mar 2014

ZO Skin Health, Cellogique announce launch of ZO Medical products in Middle East

ZO Skin Health, Inc. and Cellogique Corporation are pleased to announce the launch of the ZO Medical product line to the Middle East region at The Dubai World Dermatology & Laser Conference & Exhibition – Dubai Derma, April 8-10, 2014.

31 Mar 2014

First Edition: March 31, 2014

Today's early morning highlights from the major news organizations offer assessments of the administration's campaign to get people signed up for health care and a look at the issues going forward after today's deadline for most enrollments.

31 Mar 2014

Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Amgen (NASDAQ: AMGN) today announced new detailed data from three Phase 3 studies that showed treatment with its novel investigational cholesterol-lowering medication, evolocumab (AMG 145), resulted in a statistically significant reduction of 55-66 percent in low-density lipoprotein cholesterol (LDL-C) compared to placebo in patients with high cholesterol.

31 Mar 2014

Research News and Research

Men with long-term HIV infections at higher risk of developing plaque in their coronary arteries

Health care spending growth hits decade high

Sleep fragmentation, poor sleep quality associated with decline in executive function

Extreme summer heat in Montreal may have effect on early-term deliveries

Retinoic acid helps turn pre-cancer cells back to normal healthy breast cells

Cognitive deficits in bipolar patients ‘not homogenous’

Americans' experience with health law depends on where they live

Artists benefit from health law, but rural residents may pay more

Cellulose nanofiber paper filter removes virus particles with high efficiency

CytRx’s aldoxorubicin receives European orphan medicinal product designation for treatment of advanced soft tissue sarcomas

Bariatric surgery patients report better quality of life

Concert Pharmaceuticals announces 2013 year-end results; posts record revenue of $25.4M

New study shows anti-anxiety drugs and sleeping pills associated with increased risk of death

ICON agrees to acquire Aptiv Solutions for $143.5 million

ZO Skin Health, Cellogique announce launch of ZO Medical products in Middle East

First Edition: March 31, 2014

Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Genetic markers could help predict heart attack in patients with heart disease

New FDA Roadmap App helps sponsors improve clinical research

Forest Laboratories, Richter report positive results from cariprazine Phase IIb trial for bipolar depression

Spectroscopy Applications in the Environment eBook eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy